Variables |  | Modified group (n = 53) | Control group (n = 54) | t | p |
---|---|---|---|---|---|
Sex | Male | 28(52.8%) | 30(55.6%) | 0.080 | 0.777 |
Female | 25(47.2%) | 24(44.4%) | |||
Age(year) |  | 62.09 ± 11.23 | 64.59 ± 9.26 | 1.257 | 0.212 |
BMI(kg/m2) |  | 21.25 ± 2.93 | 21.75 ± 3.18 | 0.844 | 0.400 |
ASA | I | 7(13.2%) | 8(14.8%) | -0.157 | 0.875 |
II | 27(50.9%) | 25(46.3%) | |||
III | 19(35.8%) | 21(38.9%) | |||
Tumor locations | Ileocecal section | 18(34.0%) | 17(31.5%) | 0.096 | 0.953 |
Ascending colon | 25(47.2%) | 27(50.0%) | |||
Hepatic flexure | 10(18.9%) | 10(18.5%) | |||
Preoperative Hb level (g/L) |  | 107.36 ± 20.32 | 105.07 ± 16.39 | -0.641 | 0.523 |
Preoperative Alb level (g/L) |  | 41.68 ± 5.66 | 40.13 ± 5.21 | -1.473 | 0.144 |
Comorbidity | Yes | 18(34.0%) | 24(44.4%) | 1.233 | 0.267 |
No | 35(66.0%) | 30(55.6%) |